Recursion Pharmaceuticals Stock (RXRX) Soars 15% on a $10M Milestone Payment from Sanofi
Recursion Pharmaceuticals stock gained nearly 15% on Thursday thanks to a drug candidate update and milestone payment.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bailard Inc Thomas Bailard | 25,750 | $1,061,673 | -3% | 0.02% |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,990,147 | $81,798,390 | 0.41% | |
| 2. | 602,300 | $24,832,829 | 1.26% | |
| 3. | 273,667 | $11,283,290 | 1.2% | |
| 4. | 215,365 | $8,758,459 | 0.02% | |
| 5. | 143,750 | $5,926,832 | 0.06% |